Depyrogenated Sterile Empty Vials Market Size By Product (2 ml, 5 ml, 10 ml, 20 ml, More than 20 ml), By End-use (Clinical Labs, Compounding Labs, Pharmaceutical Manufacturers), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Jun 2019  |  Report ID: GMI3058  |  Authors: Sumant Ugalmugale

Report Format: PDF   |   Pages: 165   |   Base Year: 2018

Summary Table of Contents Industry Coverage Methodology

Industry Trends

Depyrogenated sterile empty vials market size was valued at 6.0 billion in 2018 and is expected to witness 4.7% CAGR from 2019 to 2025.

U.S. Depyrogenated Sterile Empty Vials Market, By Product, 2018 & 2025 (USD Million)

Get more details on this report - Request Free Sample PDF

Technological advancements in vial manufacturing process and launch of innovative vials will render positive impact on depyrogenated sterile empty vials market growth. Focus of industry players on development of affordable vials is expected to favour business growth. Development of innovative platform for fully integrated ready-to-use solution for aseptic manufacturing is expected to boost depyrogenated sterile empty vials industry growth during the analysis period.

Growing demand of compounding labs for creating personalized medicine in developed economies will drive depyrogenated sterile empty vials market. Convenience and benefits offered by compounding labs such as ability to compound medications that are not produced commercially proves beneficial for industry growth. Additionally, it specifically formulates liquid doses for patient with difficulty in swallowing pills that will accelerate the adoption of compounded drugs. Moreover, personalised medication prepared by compounding labs for corrective patient management can thus provide improved health outcomes for mainstream of patients thereby further augmenting the business growth. However, surging demand for other parenteral packaging alternatives may hinder depyrogenated empty vials market growth.

Depyrogenated Sterile Empty Vials Market Report Coverage
Report Coverage Details
Base Year: 2018
Historical Data for: 2014 to 2018 Forecast Period: 2019 to 2025
Pages: 165 Tables, Charts & Figures: 133
Geographies covered (17): U.S., Canada, Germany, UK, France, Italy, Spain, Netherlands, China, Japan, India, Australia, Brazil, Mexico, Saudi Arabia, South Africa, UAE
Segments covered: Product, End-use and Region
Companies covered (12): APG Pharma, Corning Incorporated, DWK Life Sciences, Gerresheimer, Nipro PharmaPackaging, Radpharm Scientific, Merck KGaA, SCHOTT, Stevanato Group, SGD pharma, Thermo Fisher Scientific, VWR International

Request 15% Free Customization on this Report

Depyrogenated Sterile Empty Vials Market, By Product

20ml vials segment held over 24% revenue share in 2018 and is anticipated to grow significantly by 2025. Ability of 20ml vials for storing samples and ideal for injectables packaging fosters the segmental growth. Usage of 20ml vials for decanting and transportation of small amounts of solvents accelerates the demand for such vials. Additionally, increasing adoption of 20ml vials in various clinical and research laboratories should boost business growth.

2ml vials segment is projected to witness exponential CAGR of more than 4% over the forthcoming years. Benefits offered by 2ml vials such as convenient storage of solutions, useful for sample collection and open cap design for ease of testing encourage customer preference that should upsurge the segment revenue size. Moreover, these vials are useful for testing solubility or dispersibility of materials that will increase its demand in coming years.

Depyrogenated Sterile Empty Vials Market, By End-use

Pharmaceutical manufacturers segment held over 31% revenue share in 2018 and will exhibit tremendous growth during the forecast timeline. Increasing storage of drugs such as emergency medicines and oncology coupled with high quality manufacturing units will favor the segmental growth.

Clinical labs segment was valued more than USD 1 billion in 2018 due to increasing usage of sterile vials in clinical settings. Increasing number of pharmaceutical and biotechnology projects will enhance the demand for clinical laboratories thereby fostering the segmental growth. Increasing use of depyrogenated sterile vials in clinical labs for efficient sample storage will foster segmental growth over the analysis period.

Germany Depyrogenated Sterile Empty Vials Market Size, By End-use, 2018 (USD Million)
Germany Depyrogenated Sterile Empty Vials Market Size, By End-use, 2018 (USD Million)

Get more details on this report - Request Free Sample PDF

Depyrogenated Sterile Empty Vials Market, By Region

North America depyrogenated sterile empty vials market will witness around 4% growth during the forecast timeframe. Rising prevalence of communicable and non-communicable diseases in the region is key factor driving depyrogenated sterile empty vials business growth over the coming years. Strong foothold of major business players in North America will further boost regional growth.

Asia Pacific market was valued more than USD 1.4 billion revenue in 2018. Regional growth can be attributed to rapidly increasing infectious diseases such as HIV. Moreover, changing lifestyle and rising prevalence of risk factors in the region will favor business growth. Growing number of research laboratories and clinical settings should further drive Asia Pacific depyrogenated sterile empty vials industry growth over the coming years.

Asia Pacific Depyrogenated Sterile Empty Vials Market Size, By Country, 2025 (USD Million)
Asia Pacific Depyrogenated Sterile Empty Vials Market Size, By Country, 2025 (USD Million)

Get more details on this report - Request Free Sample PDF

Competitive Market Share

Prominent industry players operating in depyrogenated sterile empty vials market include APG Pharma, Corning, DWK Life Sciences, Gerresheimer, NIPRO, Radpharm Scientific, Merck, SCHOTT, Stevanato, SGD Pharma, Thermo Fisher Scientific and VWR International. These industry players implement various strategies such as collaborations, acquisition and novel product launch to withstand in market and sustain industry competition. For instance, in July 2017, Gerresheimer collaborated with Corning Incorporated. This strategy aimed at delivering new corning Valor glass to the pharmaceutical packaging market. Valor’s superior strength and chemical durability result in better protection for drug products. This strategy enabled company to enhance its product portfolio.

Depyrogenated Sterile Empty Vials Industry Background

Packaging pharmaceutical products is a broad multi-faceted and encompassing task. It differs substantially from other packaging and is challenging and requires the application of large amount of scientific as well as engineering expertise to deliver a product. It focuses on information and knowledge from a wide range of scientific disciplines, including chemistry, material science, physical testing and engineering among others. Various companies operating in this industry focus on delivering different sizes and shapes of vials such as 2ml, 10ml and 40ml among others. Focus of industry players on introduction of novel and advanced vials have led to launch of various depyrogenated sterile empty vials over the recent years. Market players such as Gerresheimer, Stevanato, SGD pharma, Thermo Fisher Scientific and others are focusing their efforts in R&D for development of technologically advanced vials manufacturing platform. Increasing demand for depyrogenated sterile empty vials in various research laboratories and clinical settings will further drive industry growth during the forthcoming years.

Buy Now

Single User: $5,150 Access to only 1 person; cannot be shared; cannot be printed
Multi User: $7,150 Access for 2 to 5 users only within same department of one company
Enterprise User: $9,150 Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Why Global Market Insights, Inc.?

Reliability & accuracy

  • GMI is unparalleled when to comes to the quality of research and information provided to clients. Our unique methodology is designed to ensure a minimum of 90% accuracy to give our clients excellent value on their investment.

Quality & trust

  • BBB Rating - Click to Verify

Customer service

  • Over 200 experts are available across various time-zones, ready to serve clients for their research needs. Our industry experts help clients to design reports customized to their needs.

Security & compliance

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X